Your browser doesn't support javascript.
loading
The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Morrish, Emma; Wartewig, Tim; Kratzert, Andreas; Rosenbaum, Marc; Steiger, Katja; Ruland, Jürgen.
Affiliation
  • Morrish E; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
  • Wartewig T; Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany.
  • Kratzert A; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
  • Rosenbaum M; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
  • Steiger K; Center for Translational Cancer Research (TranslaTUM), Technical University of Munich, Munich, Germany.
  • Ruland J; Center of Molecular and Cellular Oncology, Yale School of Medicine, Yale University, New Haven, CT, USA.
Eur J Immunol ; 53(3): e2250147, 2023 03.
Article in En | MEDLINE | ID: mdl-36541400
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Proto-Oncogene Proteins c-vav Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Eur J Immunol Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Proto-Oncogene Proteins c-vav Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Eur J Immunol Year: 2023 Type: Article Affiliation country: Germany